Efforts to retain pain and cold/flu medications which contain codeine on the Pharmacist Only schedule are misguided, says a pain expert. “There’s a scare campaign …

A finding that cardio-respiratory fitness is more important than fat loss for people suffering so-called ‘Syndrome X’ has landed a Queensland researcher a New Investigator …

Medicines Australia has called on the Federal Government to make a patient’s medication records a mandatory inclusion in eHealth profiles to improve the safe use …

NPS MedicineWise has launched a new learning program and health professional resources on osteoporosis to assist in identification of patients at increased risk of osteoporosis, …

More doses of insulin are missed when using sliding-scale insulin dosing to manage hospital patients’ blood glucose levels compared with basal–bolus dosing, according to a …

An international study led by University of Queensland researchers has tracked the re-emergence of scarlet fever, a childhood disease which had largely disappeared over the …

Blooms The Chemist, has announced Apotex as its Strategic Partner of the Year at the group’s 2015 Pharmacy Awards held in Hong Kong. The award …

ASMI’s Deon Schoombie takes a look at how the prototype real-time monitoring system for OTC codeine would work During the last few weeks there has …

Chemical warfare, or the focus on retail and profit, is killing the community pharmacy, writes Mouhamad Zoghbi Today’s business culture has become cutthroat. There is …

When a patient presents at a pharmacy with a private prescription not covered by the PBS, most patients are disappointed by the benefits they receive …

A new atypical antipsychotic medication that provides a sustained improvement of the symptoms of schizophrenia with negligible effect on patients’ metabolic parameters has been welcomed by Australian experts.

Consumers will need to be prepared for the changes flowing from the PBS delisting of 17 types of medicines on 1 January 2016, says the …